NEW YORK--(BUSINESS WIRE)-- Neurogene Inc. (NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results